Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform (SMAART MAP) Trial Protocol
Abstract
In much of sub-Saharan Africa (SSA), malaria remains a key cause of paediatric hospital admission, and makes a substantial contribution to under 5-year mortality, estimated at 600,000 deaths annually. Despite implementing currently effective, fast-acting artemisinin-based combination therapies inpatient mortality for paediatric severe malaria remains unacceptably high at ~8%. The Severe malaria in Africa Research and Trials consortium-Master Adaptive Platform Trial (SMAART-MAP trial (ISRCTN79071535)) is a multi-country trial enrolling children aged >3 months and 1.5 upper limited of normal). The platform trial is simultaneously evaluating three adjunctive therapies in Phase II trials across SSA, addressing interventions against specific severe malaria complications, specifically, 1) Seizure prophylaxis with levetiracetam for children presenting with cerebral malaria; 2) Whole blood or red cell concentrates transfusion for children presenting with severe anaemia and 3) renal protection with paracetamol (15 mg/kg every 6 hours) in children with renal impairment. The trial is being run in eight hospitals across six African countries (Ghana, Democratic Republic of Congo, Uganda, Kenya, Zambia and Mozambique). Each trial has an early (~72 h) biomarker or clinical therapeutic efficacy endpoint based on putative mechanisms of action. The overarching goal is to identify the most promising interventions to take forward into a large Phase III/IV mortality endpoint trial.
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.